Releases - Nobel Biocare

View:
 

Found press releases

 

New Head of Investor Relations at Nobel Biocare

As of January 5, 2004 Suha Demokan (37) will join Nobel Biocare as the
Head of Investor Relations. The Investor Relations function will be
enhanced to address the increasing needs of stock exchanges,
shareholders, investors, financial analysts and the media. This function
will report directly to the Chief Executive Officer Heliane Canepa.

Suha Demokan has been with Centerpulse AG in...

Interim Report 3, 2003

Interim Report 3, January - September 2003
22 October 2003
Nobel Biocare Group

Positive growth momentum and continued profitability increase in Q3 2003
Revenue was up 17.4% in local currencies excluding sales of the
discontinued Gore products in the third quarter; 14.3% in local
currencies including Gore products. Profit from operations (EBIT),
before restructuring expenses...

Nobel Biocare to launch NobelPerfect implant

Nobel Biocare to launch the NobelPerfecttm dental implant for natural
esthetics

Nobel Biocare, the world leader in innovative dental solutions, will
this week introduce a unique patented implant called NobelPerfecttm at
the American Academy of Oral and Maxillofacial Surgeons (AAOMS)
scientific meeting in Orlando, USA.

NobelPerfecttm is the first implant that effectively...

Interim Report 2, Jan-June 2003

Interim Report 2, January - June 2003
13 August 2003
Nobel Biocare Group

Strong Sales and Profitability Growth in the Second Quarter

- Revenue was up 19.8% in local currencies in the Second Quarter; 20.6% in
local currencies excluding sales of the discontinued Gore products.
Profit from operations (EBIT), before restructuring expenses in 2002,
increased by 27.6% and...

Nobel Biocare to end distribution of Gore Regenerative Products

Nobel Biocare will end distributing the regenerative dental products
from W.L.Gore & Associates, Inc., May 31, 2003. Sales of the Gore
regenerative products amounts to approximately two percent of Nobel
Biocare's total sales.

"Nobel Biocare considers regenerative techniques as an important
procedure for some indications of dental implant therapy and the company
is involved in...

Press release Nobel Biocare Holding AG

1st Annual General Meeting in Nobel Biocare Holding AG, 24 April 2003 in
Zurich, Switzerland

The Annual General Meeting on 24 April, 2003, approved a dividend of CHF
0.79 gross per bearer share of CHF 2.-- nom. on the share capital
entitled to dividends = total CHF 19.842.654.--.
The dividen will be paid on 29 April, 2003, which is also the ex-
dividend day.

The...

Q1 Report, 2003

Interim Report 1, January - March 2003
24 April 2003
Nobel Biocare Holding AG Group

* Net profit increased by 38.7% to EUR 14.7 million in the first quarter
confirming that further profitability improvements were achieved in the
production related processes and that operating expenses were kept under
control.

* Revenue increased by 11.8% (currency-adjusted) to EUR 79.8...

Invitation AGM 2 April 2003

Nobel Biocare Holding AG, Zurich

Invitation to the 1st Annual General Meeting in Nobel Biocare Holding
AG, 24 April 2003 in Zurich, Switzerland

The Annual General Meeting will be held on Thursday, April 24, 2003, at
10:30 a.m.
at the UBS-Konferenzgebäude, Grünenhof, Nüschelerstrasse 9, 8001 Zurich,
Switzerland,
Auditorium on the 2nd floor, (doors open at 9:30 a.m.)

Compulsory purchase of minority shares in Nobel Biocare AB (publ)

Nobel Biocare Holding AG (a Swiss company) acquired more than 98 per
cent of the total number of shares and votes in Nobel Biocare AB (publ)
(a Swedish company) in 2002.

In order to be able to purchase the remaining shares, Nobel Biocare
Holding AG has transferred all of it shares in Nobel Biocare AB to a
wholly owned Swedish subsidiary, Nobel Biocare Sverige AB. (Compulsory

Capital Markets Day at Nobel Biocare

Nobel Biocare has invited to a Capital Markets Day in Gothenburg,
Sweden, today. Two live operations featuring the latest achievements in
dental implants will be the highlights of the day at the Nobel Biocare
Training Center.

Participants will be able to witness immediate single-tooth replacement
carried out with the new Replace Select products. They will also be
given a glimpse...

Nobel Biocare

Nobel Biocare is the world leader in innovative esthetic dental solutions with the brands Brånemark System® ,Replace® Select and Procera®.Nobel Biocare has around 1,300 employees and, in 2001 net sales totaled SEK 2 663 ...

View more


  CONTACT